文献速递糖尿病

间歇扫描式持续葡萄糖监测在胰岛素治疗2型糖尿病中的实施与住院及医疗费用变化

Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2026-01-01

该研究评估了在胰岛素治疗的2型糖尿病成人中全面实施间歇扫描式持续葡萄糖监测(isCGM)对住院率、住院时长和住院费用的影响。结果显示,isCGM启动后糖尿病相关住院率显著下降,住院时长缩短,总住院费用降低,但心血管住院率保持稳定,其趋势在isCGM启动后相对于干预前趋势发生变化。

要点

  • isCGM实施与糖尿病相关住院率显著下降相关(RR 0.37)。
  • isCGM实施与住院时长中位数缩短(从4天降至3天)相关。
  • isCGM实施与总住院费用降低相关,但心血管住院率保持稳定。

核心结论

  • 在真实世界中,对胰岛素治疗的2型糖尿病成人实施isCGM与急性糖尿病相关住院大幅减少、住院时间缩短、医疗费用降低及心血管住院趋势改变相关。

主要发现

  • 平均HbA1c从8.09%降至7.65%(平均差-0.44% [95%CI -0.47至-0.42])。
  • 糖尿病相关住院率从74.6降至27.5每万人年(RR 0.37 [95%CI 0.28-0.49])。
  • 心血管住院率保持稳定(228.8 vs. 215.8每万人年;RR 0.94 [95%CI 0.84-1.06])。
  • 住院时长中位数从4天(四分位距5)降至3天(四分位距4)。
  • 总住院费用减少3,806,776.90美元(每万人年减少955,186.70美元)。

临床怎么用

  • 对于每日多次胰岛素注射的2型糖尿病成人,实施isCGM可能有助于减少急性糖尿病相关住院、缩短住院时间并降低医疗费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of a population-wide implementation of intermittently scanned continuous glucose monitoring (isCGM) on hospitalization rates and trends, length of stay, and inpatient health care costs among adults with insulin-treated type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: This population-based, longitudinal, quasi-experimental cohort study included adults with T2D taking multiple daily insulin injections who initiated publicly funded isCGM between April 2022 and December 2023. Hospitalizations for acute diabetes-related complications (diabetic ketoacidosis, hyperglycemic hyperosmolar state, simple hyperglycemia, and hypoglycemia) and cardiovascular complications (myocardial infarction, stroke, and major lower-extremity amputation) were identified using ICD-10 codes. Incidence rates and rate ratios (RRs) were estimated using Poisson models. Interrupted time series analyses were used to estimate counterfactual trends. RESULTS: Among 15,413 participants, the mean follow-up was 22.5 ± 4.6 months before and 19.1 ± 4.4 months after isCGM initiation. Mean HbA1c decreased from 8.09 to 7.65% (mean difference -0.44 [95% CI -0.47 to -0.42]). Diabetes-related hospitalization rates decreased from 74.6 to 27.5 per 10,000 person-years (RR 0.37 [95% CI 0.28-0.49]). Cardiovascular hospitalization rates remained stable (228.8 vs. 215.8 per 10,000 person-years; RR 0.94 [0.84-1.06]). Interrupted time series analyses showed a change in cardiovascular admission rates after isCGM initiation relative to the preintervention trend. Median length of stay decreased from 4 (interquartile range 5) to 3 (4) days. Total inpatient costs decreased by $3,806,776.90 (-$955,186.70 per 10,000 person-years). CONCLUSIONS: In this real-world study, implementation of isCGM among insulin-treated adults with T2D was associated with substantial reductions in acute diabetes-related hospitalizations, shorter hospital stays, lower health care costs, and changes in cardiovascular hospitalization trends.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Rodríguez de Vera Gómez P, Mayoral E, Rodríguez Jiménez B, et al. Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes. Diabetes Care. 2026. PMID: 42301188. doi:10.2337/dc26-0547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。